Joshua Reed | CFO |
Todd Brady | CEO, President & Director |
Neil Carnahan | Stifel, Nicolaus & Company |
Elemer Piros | Cantor Fitzgerald & Co. |
I-Eh Jen | Laidlaw & Company |
Corey Davis | Seaport Global Securities |
Good day, and welcome to the Aldeyra Therapeutics Second Quarter 2018 Conference Call. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Joshua Reed, Chief Financial Officer. Please go ahead.